普爱药业品牌怎么样 申请店铺

我要投票 普爱药业在医疗保健行业中的票数:583 更新时间:2026-01-24
普爱药业是哪个国家的品牌?「普爱药业」是 湖北普爱药业有限公司 旗下著名品牌。该品牌发源于湖北省武汉市,由创始人刘 * 乡在1998年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力普爱药业品牌出海!将品牌入驻外推网,定制普爱药业品牌推广信息,可以显著提高普爱药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

普爱药业怎么样

湖北普爱药业有限公司,成立于1998年3月,是湖北省贴敷类医疗器械生产行业的龙头企业。位于武汉市东西湖风景优美的台商投资区银湖科技园内,厂房建筑面积约2万平方米,拥有10万级标准净化车间。是集医药产品研发、生产和销售于一体的现代化医疗器械生产企业。公司技术力量雄厚,拥有先进的生产、检测设备和完善的质量保证体系,公司同时拥有一家子公司:湖北普爱医疗器械有限公司,主营国内外各类医疗器械产品。

公司是中国较早的“暖宫贴”生产商,起草并制定了“暖宫贴”的行业标准。金月子暖宫贴是公司根据《中国药典》中坎离砂的原理,于2000年自主研发的产后护理产品。2003年2月,金月子暖宫贴经湖北省食品药品监督管理局批准正式生产。2004年“金月子”商标经国家商标局批准注册。金月子上市以来,产品质量和疗效得到广大用户的认可。“坐月子、金月子”,成为现代女性产后护理的健康时尚。金月子现已成为中国暖宫贴类重量级品牌,在全国大部分医院妇产科均有销售。2006年金月子开始进军欧美市场。

公司经过多年的不懈努力,发展迅速,相继自主研发推出金月子暖宫贴、远红外止咳贴、烫熨治疗包、隔物灸、远红外痛经贴、远红外磁疗贴、壳聚糖止血粉、壳聚糖伤口护理膜、壳聚糖妇科凝胶、非织造壳聚糖护创材料(速愈贴)、皲裂贴、退热贴、通气鼻贴、医用冰垫、消毒制剂等近五十种医疗产品。


Hubei puai Pharmaceutical Co., Ltd., founded in March 1998, is the leading enterprise in the field of medical equipment manufacturing in Hubei Province. It is located in Yinhu science and Technology Park, a beautiful Taiwanese Investment Zone in East and West Lakes of Wuhan City, with a building area of about 20000 square meters and 100000 level standard purification workshops. It is a modern medical device manufacturer integrating research and development, production and sales of medical products. The company has strong technical force, advanced production and testing equipment and perfect quality assurance system. At the same time, the company has a subsidiary: Hubei puai Medical Equipment Co., Ltd., which is mainly engaged in all kinds of medical equipment products at home and abroad. The company is an earlier manufacturer of "warm palace stickers" in China, and has drafted and formulated the industry standard of "warm palace stickers". Jinyuezi warm palace paste is a postpartum care product independently developed by the company in 2000 according to the principle of canlisha in Chinese Pharmacopoeia. In February 2003, jinyuezi warm palace paste was officially produced with the approval of Hubei food and drug administration. In 2004, "jinyuezi" trademark was approved and registered by the State Trademark Office. Since jinyuezi came into the market, the product quality and efficacy have been recognized by the majority of users. "Sitting on the moon, Golden Moon" has become a health fashion of post natal care for modern women. Jinyuezi has become a major brand of warm palace stickers in China, which are sold in most hospitals in the country. In 2006, annuity began to enter the European and American market. After years of unremitting efforts, the company has developed rapidly, and has launched research and development independently, including Jin Yue Zi warm palace paste, far-infrared cough patch, ironing treatment bag, septic moxibustion, far-infrared dysmenorrhea sticker, far-infrared magnetic therapy paste, chitosan hemostatic powder, chitosan wound nursing film, chitosan gynecological gel, nonwoven chitosan protective materials (fast healing paste), chapped paste, antipyretic patch, ventilation nasal paste, etc. There are nearly 50 kinds of medical products such as medical ice pad and disinfectant.

本文链接: https://brand.waitui.com/e96516099.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

刚刚

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

刚刚

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

刚刚

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

刚刚

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

刚刚

本页详细列出关于普爱药业的品牌信息,含品牌所属公司介绍,普爱药业所处行业的品牌地位及优势。
咨询